NTSR1

Across TCGA pan-cancer cohorts, NTSR1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated NTSR1 data layer compared with 25 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher NTSR1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated NTSR1 expression acts as an unfavorable survival marker.

GBM, LSCC, and LUAD are the cancer types where NTSR1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	DFS	Median	All	0.205	0.379	.002	14	view →
LSCC	OS	Median	All	0.898	1.000	.010	11	view →
LUAD	OS	Median	III,IV	0.651	1.000	.022	3	view →
HNSC	DFS	Median	All	0.578	0.868	.031	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

NTSR1–GBM (DFS)

Open the GBM breakdown →